2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
3
Glioblastoma
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Locally Advanced Rectal Carcinoma
1
Hypoxia
1
Gliosarcoma
1
Glioma
1
Genetic Diseases, Inborn
1
Esophageal Neoplasms
1
Circulating Tumor DNA
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
tislelizumab
1
envafolimab
1
durvalumab
1
Nivolumab
1
Neoadjuvant Therapy
1
Circulating Tumor DNA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Carcinoma
×
Circulating Tumor DNA
×
Clear all
NCT05601505
2024-12-24
CINTS-R
Peking Union Medical College Hospital
Phase 2
Recruiting
470 enrolled